과학
중도 성향
STAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit
STAT News
On secondary endpoints that looked at major cardiovascular events, those taking retatrutide did not have a significant lower risk of death, heart attack, or stroke. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'science' 카테고리 뉴스
Drought, water shortages and crop failures: How does the medieval warm period compare with today?
Phys.org
American Indian and Alaska Native adults in California struggle with chronic disease and substance use, study finds
Medical Xpress
A mother's devotion to newborns begins in the brain, study suggests
Medical Xpress